Google Alert - news

	news As-it-happens update ⋅ May 29, 2024
	NEWS
	BSA bureau FDA Approves First Interchangeable Biosimilar for Two Rare Diseases FDA.gov Today, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat certain rare diseases. Bkemv is approved for the following treatment indications, which are also ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback